189 related articles for article (PubMed ID: 33616708)
1. Comorbidity and frailty assessment in renal cell carcinoma patients.
Courcier J; De La Taille A; Lassau N; Ingels A
World J Urol; 2021 Aug; 39(8):2831-2841. PubMed ID: 33616708
[TBL] [Abstract][Full Text] [Related]
2. Frailty predicts outcome of partial nephrectomy and guides treatment decision towards active surveillance and tumor ablation.
Walach MT; Wunderle MF; Haertel N; Mühlbauer JK; Kowalewski KF; Wagener N; Rathmann N; Kriegmair MC
World J Urol; 2021 Aug; 39(8):2843-2851. PubMed ID: 33515329
[TBL] [Abstract][Full Text] [Related]
3. Assessment of prevalence and clinical outcome of frailty in an elderly predialysis cohort using simple tools.
Ali H; Abdelaziz T; Abdelaal F; Baharani J
Saudi J Kidney Dis Transpl; 2018; 29(1):63-70. PubMed ID: 29456209
[TBL] [Abstract][Full Text] [Related]
4. Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry.
Kim JK; Kim SH; Song MK; Joo J; Seo SI; Kwak C; Jeong CW; Song C; Hwang EC; Seo IY; Lee H; Hong SH; Park JY; Chung J
Cancer Res Treat; 2019 Apr; 51(2):758-768. PubMed ID: 30189720
[TBL] [Abstract][Full Text] [Related]
5. Evolving Clinical Picture of Renal Cell Carcinoma: A Population-Based Study from Helsinki.
Erkkilä K; Tornberg SV; Järvinen P; Järvinen R; Kilpeläinen TP; Visapää H; Hervonen P; Taari K; Nisen H
Urol Int; 2019; 102(4):390-398. PubMed ID: 30636255
[TBL] [Abstract][Full Text] [Related]
6. [Geriatric specificities of localized renal cell carcinoma].
Mongiat-Artus P; Paillaud E; Caillet P; Albrand G; Neuzillet Y
Prog Urol; 2019 Nov; 29(14):865-873. PubMed ID: 31771769
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma in the Canadian Indigenous population.
Wong ECL; Breau RH; Mallick R; Wood L; Pouliot F; Basappa NS; Tanguay S; Soulières D; So A; Heng D; Lavallée LT; Drachenberg D; Kapoor A
Curr Oncol; 2019 Jun; 26(3):e367-e371. PubMed ID: 31285681
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
9. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
10. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
11. Active Surveillance in Small Renal Masses in the Elderly: A Literature Review.
Cheung DC; Finelli A
Eur Urol Focus; 2017 Oct; 3(4-5):340-351. PubMed ID: 29175368
[TBL] [Abstract][Full Text] [Related]
12. FRAIL Questionnaire Screening Tool and Short-Term Outcomes in Geriatric Fracture Patients.
Gleason LJ; Benton EA; Alvarez-Nebreda ML; Weaver MJ; Harris MB; Javedan H
J Am Med Dir Assoc; 2017 Dec; 18(12):1082-1086. PubMed ID: 28866353
[TBL] [Abstract][Full Text] [Related]
13. [Renal cell carcinoma in older and geriatric patients].
Wagener N
Urologe A; 2017 Aug; 56(8):1019-1024. PubMed ID: 28451746
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center study.
Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Martini A; Tian Z; Karakiewicz PI; Mottrie A; Boarin M; Villa G; Trevisani F; Marandino L; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
Urol Oncol; 2023 Mar; 41(3):149.e17-149.e25. PubMed ID: 36369233
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
17. [Specificity of the management of metastatic renal cancer in the older patient].
Neuzillet Y; Albrand G; Caillet P; Paillaud E; Mongiat-Artus P
Prog Urol; 2019 Nov; 29(14):874-895. PubMed ID: 31771770
[TBL] [Abstract][Full Text] [Related]
18. Role of Active Surveillance for Localized Small Renal Masses.
Mir MC; Capitanio U; Bertolo R; Ouzaid I; Salagierski M; Kriegmair M; Volpe A; Jewett MAS; Kutikov A; Pierorazio PM;
Eur Urol Oncol; 2018 Aug; 1(3):177-187. PubMed ID: 31102618
[TBL] [Abstract][Full Text] [Related]
19. A scoping review of the Clinical Frailty Scale.
Church S; Rogers E; Rockwood K; Theou O
BMC Geriatr; 2020 Oct; 20(1):393. PubMed ID: 33028215
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome for metastatic papillary renal cell carcinoma patients.
Ronnen EA; Kondagunta GV; Ishill N; Spodek L; Russo P; Reuter V; Bacik J; Motzer RJ
Cancer; 2006 Dec; 107(11):2617-21. PubMed ID: 17083126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
